Linnea Inc. and Artemis International Form Co-Marketing Agreement
Artemis’ Range of Berry Extracts and PhytoSolutions(TM) Proprietary Formulations
to be Sold Through Linnea
(download pdf 80K)
Anaheim, CA – March 9, 2007 – Linnea Inc. and Artemis International Inc. announce the formation of a marketing collaboration for the sales and promotion of Artemis’ range of berry extracts and PhytoSolutionsTM proprietary formulations. This joint announcement was made at Expo West. . .
HMRlignan™ Provides Cardiovascular Protection through Alleviation of Inflammatory Pathways, New Study Reveals
(download pdf 47K)
Anaheim, CA – March 9, 2007 – Linnea has announced the results of a new study that shows that 7-hydroxymatairesinol (HMRlignan(TM), HMR) ingestion may provide cardiovascular protection by depressing a particular inflammatory pathway. The study, concluded in February, was performed by the Department of Clinical Medicine at the University of Insubria in Italy and is under preparation for publication.
. .
Study Shows Relationship between Lignans and Uterine Fibroids
Findings suggest a modest inverse association between lignan excretion
and risk of uterine fibroids.
(download pdf 98K)
October 20, 2006 - A new study published in the American Journal of Clinical Nutrition (2006; v84, 587-93), has demonstrated a possible relationship between lignans and risk of uterine fibroids. . .
New Study Identifies 7-Hydroxymatairesinol as Key Lignan in Food Sources
Norway spruce remains most potent and economical source of direct enterolactone precursor (download pdf 108K)
October 19, 2006 - Linnea, the exclusive supplier of HMRlignan(TM), announced today that new Finnish research has uncovered the naturally occurring existence of 7-hydroxymatairesinol as the dominant lignan in wheat, triticale, barley, corn, amaranth, millet and oat bran. . .
Donald Brown, N.D. Discusses the Key Roles of Enterolactone in Women's Health at SupplySide West
(download pdf 100K)
October 19, 2006 - Of the numerous biomarkers that indicate health status in women, the human lignan enterolactone is becoming known in the medical research community for its potential health benefits and prevention of certain diseases in women, most notably breast cancer. . .
Your Enterolactone Levels are Low, In Case Your Wondering, That is a Bad Thing
Lee Swanson, President of Swanson Health Products
(download pdf 820K)
July 2, 2006 - Since reading the groundbreaking research on Enterolactone, and how their levels can be naturally raised in the body by a 100% natural food supplement like the Linnea Norwegian SpruceLignans, I was determined to develop and introducethis product, HMRlignan™ into our Swanson Health Products catalog as soon as it was approved for use here in theUnited States.
New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans
(download pdf 55k)
Secaucus, NJ - May 2, 2006 - Linnea has announced that new research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the multiple mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans.
Several lines of evidence suggest that plant-derived dietary lignans may play a role in chemoprevention and prostate health promotion, through complex pharmacological activities that may include pro or anti-estrogenic, pro-apoptotic, antioxidant, and anti-angiogenic mechanisms. In particular, in-vivo research had shown the novel lignan, hydroxymatairesinol (HMRlignan), and its human lignan metabolite enterolactone, to inhibit tumor growth rate and tumor take rates in animal models (Bylund et al, Exp Biol Med , March 2005). . .
New Research Establishes EC50 Values for Norwegian Spruce Lignans (HMRlignan™) Efficacy In Managing Menopause
Study confirms 10mg - 30 mg dose for lignan supplement
(download pdf 104k)
ANAHEIM, CA - March 24, 2006 - New research performed by the clinical medicine faculty at the University of Insubria in Italy has added to the body of evidence supporting the use of lignan phytoestrogens to help women manage menopause. In the study, designed to establish the effective median concentration value (EC50) of Norway spruce-derived lignan, hydroxymatairesinol and its human metabolite enterolactone in comparison to estradiol, experiments confirmed a daily dosage 10 mg - 30 mg as sufficient to raise circulating enterolactone to estrogenically active levels.
. .
Norwegian Spruce Lignans Address Women's Health Issues and Heart Health
Directly Raising Enterolactone Levels is the Key to Benefits
(download pdf 120k)
ANAHEIM, CA - March 24, 2006 - A new dietary supplement ingredient, HMRlignan™, from Linnea Inc. will be raising consumers' awareness and interest in their circulating enterolactone levels. . .
Enterolactone Supports Prostate Health
New Research Indicates the Lignan Metabolite Enterolactone, Not Parent Lignans,
Key For Prostate Health
(download pdf 104k)
EASTON, PA - March 8, 2006 - Linnea, the exclusive supplier of HMRlignan™ announced today that a new Swedish study evaluated the association between serum enterolactone and risk of prostate cancer. In the study, entitled, "Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the Cancer Prostate Sweden Study," by Hedelin, M., et al; ( Cancer Causes and Control (2006) 17:169-180), the authors concluded that there was a positive mechanistic association between serum enterolactone concentration and risk of prostate. . .
HMRlignan™ : Viable Support for Women's Health Issues
Linnea Seminar At SupplySide West Focus on Applications for
Women's Health Concerns
(download pdf 108k)
LAS VEGAS, NV - November 9, 2005 - Dr. Mikko Unkila, a published expert in lignan pharmacology from Finland, will discuss the research and merits of the novel patented compound, HMRlignan™ , for use in dietary supplements and functional foods targeting women's health issues, such as breast health, cardiovascular health and the management of menopause. The presentation entitled, "HMRlignan™ : A Novel Source of Dietary Lignans and a Soft Phyto-hormonal Approach for Sustainable Women's Health Support," will be featured today as a seminar at SupplySide West. The seminar is hosted by Linnea Inc. . .
Linnea Awarded Kosher Certification for Brand Portfolio
Another Step in Quality Assurance Propels Supplier to Forefront
(download pdf 96k)
LOCARNO, SWITZERLAND & EASTON, PA - November 9, 2005 - Linnea SA has announced it has received Kosher and Parve certification on its entire portfolio of botanical raw materials from Services International Kosher Supervision, Ltd., a non-profit organization based dually in Jerusalem and in Torino, Italy. . .
Linnea Launches an Industry First:
HMRlignan™ - Direct Enterolactone Precursor
(download pdf 100k)
LOCARNO, SWITZERLAND & EASTON, PA - August 17, 2005 - Linnea SA announced today the launch of an innovative lignan compound, HMRlignan™, a patented product developed in Finland by Hormos Medical Corporation, and manufactured and marketed worldwide under license by Linnea, Switzerland. Linnea SA is a specialist manufacturer of botanical extracts and phytochemicals for the pharmaceutical, dietary supplement and cosmetic industries. . .
Introducing HMRlignan™: A Novel Enterolactone Precursor and More Digestible Source of Lignans
By Dr. Lauri Kangas, Senior Scientific Advisor, Hormos Medical Corporation and
Robin Ward, Vice President of Marketing, Linnea Inc.
(pdf download 112k)
On April 19, 2005, the USDA unveiled a new Food Pyramid. In the USDA's introductory report, entitled, "Dietary Guidelines for Americans 2005," under chapter 5, "Food Groups to Encourage," the USDA places emphasis on consumption of whole grains. It reads, "In the grain-refining process, most of the bran and some of the germ is removed, resulting in the loss of dietary fiber (also known as cereal fiber), vitamins, minerals, lignans, phytoestrogens [emphasis added by author] phenolic compounds, and phytic acid. . .
HORMOS licenses HMRlignan™ to LINNEA
(pdf download 164k)
Hormos Medical Corporation has signed a world-wide license agreement for its dietary supplement ingredient HMRlignan™ with the Swiss botanical ingredient manufacturing company Linnea SA . . .
